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A
s scale-up of antiretroviral 
therapy (ART) progresses in 
less-developed countries, the 
challenges of providing treatment to 
marginalised populations become 
of increasing concern. One such 
marginalised group is prisoners. While 
there is an emerging consensus that 
prevention and treatment is feasible 
and effective in prisons [1], experience 
of implementing comprehensive 
HIV/AIDS programmes that include 
antiretroviral therapy in resource-
limited countries is limited. This article 
describes our experience of providing 
HIV prevention and treatment in two 
prisons in Thailand.
HIV in Prisons in Thailand
Thailand is noted for its successful 
response to the HIV epidemic. 
Successful prevention efforts achieved 
an 83% reduction in new infections 
between 1990 and 2003, and the 
country can be said to have achieved the 
goal of universal access to antiretroviral 
therapy, with about 76,000 people on 
treatment out of a total of roughly 
600,000 people with HIV [2]. However, 
several groups have been unable to 
access the government’s treatment 
programme, in particular injecting drug 
users, migrants, and prisoners (the ﬁ  rst 
two groups contributing signiﬁ  cantly to 
the third) [3].
A reported 168,264 people are 
incarcerated in Thailand (point 
prevalence), exceeding prison capacity 
by over 50% [4]. Prison data on 
HIV prevalence are sparse—testing 
is not performed systematically 
and no random surveys have been 
done—but what data do exist indicate 
that prevalence is much higher than 
in the general population [5]. One 
study in Klong Prem Central Prison, 
Bangkok, found that 25% of prisoners 
who agreed to be tested (n = 689; 
convenience sample) were HIV positive 
[6], compared to a general prevalence 
of 1.5% in the national population [2].
Thailand’s prisons suffer from lack 
of health staff and severe budget 
constraints. The health care workforce 
in the 139 prisons across Thailand 
comprises just 17 full-time and 16 part-
time doctors and 307 nurses. In 2000, 
Thailand spent over US$150 million 
on prison health care (including 
infrastructure-related costs), but less 
than US$25,000 was spent on HIV/
AIDS care [7]. Until October 2005, the 
total annual health budget per prisoner 
was around US$3.5, disbursed through 
the Department of Corrections. Since 
then, the prison health budget has 
come under the administration of 
the National Health Security Ofﬁ  ce’s 
health insurance scheme. This scheme 
covers treatment for most health 
conditions, including HIV/AIDS, thus 
removing budgetary constraints for the 
treatment of most patients. However, 
health insurance is only available to 
registered Thai nationals. Around 
5% of the total prison population 
are foreign nationals, mostly 
from Myanmar, and an additional 
unknown but signiﬁ  cant number are 
unregistered Thais (ethnic minorities, 
nationals without birth registration, or 
those who have lost their identity cards) 
[8]. In addition, the health insurance 
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Box 1. Minburi and Bangkwang Prisons
Minburi Remand Prison is a medium-security prison with a capacity of 2,000 (1,700 
males and 300 females). The duration of sentence is two to seven years. Health care staff 
are one part-time doctor and three full-time nurses. Prisoners needing hospitalisation 
are transferred to Klang Hospital, a 300-bed hospital in Klong Prem Central Prison, 
Bangkok. MSF began working in Minburi Remand Prison in June 2003.
Bangkwang is a maximum-security prison. Its ofﬁ  cial capacity is 3,500 (males only), 
but in March 2006 it held 4,922 prisoners, including 870 on death row. The minimum 
sentence is 25 years. There is a 40-bed hospital and an outpatient clinic. Health services 
are staffed by one full-time doctor (director of prison medical services) and another part-
time doctor, six registered nurses, six technical nurses, two pharmacists, one laboratory 
technician, and two x-ray technicians. MSF began working in Bangkwang in December 
2004.
Both prisons are overcrowded. Prisoners occupy large communal rooms. In Minburi 
there are about 400 prisoners per room in the male prison and 300 per room in the 
female prison. In Bangkwang there are 20 to 40 prisoners per room, except on death 
row, where there are about 100 per room. A small number of prisoners are held in 
solitary conﬁ  nement.
In both prisons, all inmates are locked in their cells from 4 pm to 7 am, during which 
time health staff do not access the cells. In Bangkwang, “ﬁ  rst aid” health care is provided 
by designated prisoner volunteers during these hours.PLoS Medicine  |  www.plosmedicine.org 0989
scheme does not fund prevention, 
education, or other non-curative 
activities.
HIV/AIDS Care in Two Prisons in 
Bangkok
Médecins Sans Frontières (MSF) has 
supported HIV/AIDS programmes 
in Thailand since 1995. In June 
2003, at the invitation of the prison 
health services, we began providing 
clinical support in two prisons in 
Bangkok—Minburi, a remand prison, 
and Bangkwang, a maximum-security 
prison (Box 1). The initial focus was on 
treatment, but once a level of trust was 
built between MSF and prison health 
authorities, we were invited to expand 
our work to prevention activities. The 
following observations are derived from 
these programmes.
Prevention
Drug users in Thailand are the highest 
risk group for HIV infection. Around 
one-ﬁ  fth of all new HIV infections 
occur through injecting drug use; in 
some parts of the country this ﬁ  gure 
rises to above 50% [3]. Up to two-
thirds of prisoners are incarcerated for 
drug-related offences [2]; some, but 
not all, are injecting drug users, and 
this contributes to the high prison HIV 
prevalence. Injecting drug use in the 
prisons has decreased in recent years, 
partly because of reduced availability 
of heroin (inside and outside). Where 
it does occur, injecting equipment is 
scarce and almost always shared. Some 
prisoners tell us that they used to 
belong to an “injecting group” but this 
stopped when other drug users started 
to die from AIDS.
Tattooing is another risk factor 
for HIV infection. In Thai prisons, 
tattooing equipment is prohibited and 
therefore it is often shared. Sharpened 
pens or sewing needles may be used for 
tattooing and there are no means for 
sterilisation.
But by far the greatest risk factor 
for HIV transmission within Thai 
prisons is unprotected sex between 
men. Sex, consensual or otherwise, is 
part of prison life (Box 2). Condoms 
are not banned from prisons, but the 
attitude of prison staff towards sex 
between prisoners inﬂ  uences condom 
distribution.
The governors of both prisons 
where we work gave approval for 
condom distribution during 2006, 
but distributing them widely depends 
on changing attitudes of prison 
staff. While health staff are generally 
supportive, the engagement of other 
staff is essential to move distribution 
beyond the clinics. Prison guards want 
to see HIV transmission reduced, 
but often ﬁ  nd it hard to accept that 
for this to occur they must play an 
active role in condom distribution. 
Progress has been made in both prisons 
through workshops in which prison 
staff are encouraged to question their 
own attitudes and behaviour towards 
prisoners, through activities such as 
role-plays. In Bangkwang condoms 
are available through prisoner 
representatives (prisoners designated 
by the Director of Medical Services and 
trained by MSF). In Minburi, where 
there is a rapid turnover of prisoners, 
prisoner representatives are less easy 
to establish and the focus is on prison 
guards, many of whom now agree to 
distribute condoms.
Workshops for prisoners give 
information about HIV transmission 
and prevention. These workshops also 
provide an opportunity for participants 
to share their experiences and learn 
from each other about how to solve 
the difﬁ  culties of establishing safer 
sexual practices in the prison. Such a 
participatory approach is also part of 
the development of mutual support 
amongst the prisoners.
HIV Testing and Counselling
In the past, prisoners generally received 
no pre- or post-test counselling. Health 
care staff may have avoided informing 
prisoners of their status because 
treatment was unavailable. We have 
seen several patients whose medical 
record showed that an HIV diagnosis 
had been made several years ago but 
the patients had not been informed 
of their status. Counselling is now 
implemented in both prisons, but not 
all prison staff believe it is necessary 
and more work is needed to explain 
its beneﬁ  ts. Conﬁ  dentiality is a major 
challenge and we have attempted to 
address this issue during workshops for 
both staff and prisoners. Nevertheless, 
during the ﬁ  rst 18 months of the 
programme, 20 prisoners failed to 
attend any follow-up counselling after 
receiving a positive HIV diagnosis.
Most patients we have seen to 
date (112 from a total of 165) were 
diagnosed with HIV infection while 
in prison, with diagnosis most often 
prompted by an opportunistic infection 
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Box 2. Sex in Prisons
 What kinds of sex occur in all-male prisons?
•  Sex in the prisons is frequently related to power.
•  Consensual sex between men includes partner sex, paid sex, and sex in exchange for 
protection.
•  Non-consensual sex includes rape, sometimes used as an intimidation tactic, and 
coerced sex as repayment of debt. New prisoners are particularly vulnerable as they 
can be subjected to sex as an initiation to the power relations in the prison.
Why may the attitude of prison staff prevent safer sex practices?
•  Some prison staff try to forbid all sexual activities in order to prevent non-consensual 
sex; others believe that forbidding sex is the most effective form of prevention, 
though in practice this is unrealistic.
Why do prisoners fail to use condoms?
•  Condoms are not banned in prison, but in practice it is difﬁ  cult to gain acceptance 
from prison guards for condom distribution.
•  Some prisoners are unaware of the risk of HIV transmission by anal sex. Others 
are aware, but are unable to access condoms or to negotiate their use in coercive 
situations.
•  Being known to have sex or to possess condoms may lead to criticism by prison 
guards or ostracism by other prisoners. Prisoners may prefer to risk becoming HIV 
positive than to try to access condoms.
•  Prisoners may believe that having sex with another man is against nature. This leads 
them to be secretive and have clandestine, unprotected sex.
•  Someone who insists on condom use can give the impression that they are HIV 
positive or have a sexually transmitted infection.PLoS Medicine  |  www.plosmedicine.org 0990
(81 patients) such as pulmonary 
tuberculosis (45 patients). Some 
former injecting drug users sought 
testing when other drug users died.
Care and Treatment for HIV/AIDS
Clinical support began with the 
treatment of opportunistic infections. 
During this phase—lasting six months 
in both prisons—prison medical staff 
and MSF jointly set up a peer support 
system for adherence to antiretroviral 
treatment.
Of 165 HIV-infected prisoners 
identiﬁ  ed since the program began, 
122 (74%) were in disease stage 
3 or 4 as deﬁ  ned by the World 
Health Organization (WHO). Most 
opportunistic infections have been 
manageable within the prison, 
including pulmonary tuberculosis 
(43 cases) and extra-pulmonary 
tuberculosis (28 cases). Two patients 
with multidrug-resistant tuberculosis, 
two with cryptococcal meningitis, and 
two with cytomegalovirus retinitis have 
been referred to an infectious diseases 
hospital for diagnosis and treatment. 
Two patients with pneumonia have 
died after referral and hospital 
admission. There is no access to 
treatment for hepatitis B and C in the 
prisons and we do not routinely test 
for these conditions. Even outside the 
prison availability of such treatment is 
extremely limited.
Medical criteria to initiate 
antiretroviral therapy follow Thai 
national guidelines: CD4 count below 
250 cells/mm3 for patients with WHO 
stage 2, 3, or 4 disease, or below 200 
in asymptomatic cases. Patients are 
provided with basic knowledge about 
HIV, opportunistic infections, ART, 
and the importance of adherence so 
that they can make informed decisions 
regarding whether and when to start 
treatment. If patients proceed to 
treatment, antiretroviral therapy is 
administered by a nurse helper—a 
volunteer prisoner who helps medical 
staff with tasks such as dispensing 
medications and checking temperature, 
weight, and blood pressure. The ﬁ  rst-
line regimen for 87 patients (75%) is 
a ﬁ  xed-dose combination of stavudine, 
lamivudine, and nevirapine [9]. Patients 
with tuberculosis co-infection who 
are taking rifampicin are prescribed 
stavudine, lamivudine, and efavirenz.
We have enrolled 88 patients on 
antiretrovirals, of whom 12 (15%) had 
previously taken ART but discontinued 
it when they were imprisoned (Table 
1). The median follow-up time on 
treatment is 18 months and CD4 cell 
gain is comparable with treatment 
programmes in other settings [9]. 
Currently we follow 63 patients on 
ART (72%) within the prisons. Of the 
remaining patients, 18 (20%) have 
been released from prison and ﬁ  ve 
(6%) were transferred to other prisons; 
two patients (2%) have died.
Peer support from people living 
with HIV/AIDS is part of Thailand’s 
treatment strategy [10], and peer 
support systems have been established 
in both prisons. In addition to this 
group support, patients are assigned 
a buddy to support adherence to 
medication (the buddy is normally 
someone who has HIV and who may 
also be on ART).
Prisons have been said to be the 
ideal environment for ensuring high 
compliance to treatment [11], but 
in our experience there are many 
important barriers to overcome that 
require constant re-evaluation. These 
include fear of stigma associated with 
HIV, which discourages prisoners 
from taking medicines in a crowded 
environment; mistrust of prison staff, 
including hospital staff; transfer 
to another facility; and poor social 
support upon release.
The attitude of the prison health 
care staff towards the rights of prisoners 
to access ART is very positive. Staff are 
committed to working through difﬁ  cult 
problems and referring people to 
other hospitals in cases where specialist 
care is needed. The fact that none 
have questioned that three prisoners 
facing the death sentence receive 
antiretroviral treatment is a clear 
indication of the staff’s commitment to 
treatment as a basic human right.
This positive attitude is crucial 
to success in a setting where the 
traditional relationship between 
prisoners and prison staff is 
antagonistic: in the past prisoners 
distrusted staff and were unwilling to 
come forward for care. According to 
the medical director in Bangkwang, 
it took two years to gain the trust of 
patients before they were willing to 
seek treatment.
Table 1. Characteristics and Outcomes of Patients with HIV Receiving ART in Two Prisons
Characteristics and Outcomes Indicators Values
Characteristics of patients receiving ART (n = 88) Male, n (%) 72 (82)
Female, n (%) 16 (18)
Mean age, y (min–max) 34 (21–49)
Median follow up in months (IQR) 18 (9–23)
WHO staging at the time of initiating ART
Stage I, n (%) 7 (8)
Stage II, n (%) 10 (11)
Stage III, n (%) 41 (47)
Stage IV, n (%) 30 (34)
Median CD4 at the time of initiating ART, cells/mm3 (IQR) 119 (23–205)
Mean CD4 cell increase in patients receiving ART (n = 14)a After 6 months ART, cells/mm3 (standard error) 73.5 (14.1)
After 12 months ART, cells/mm3 (standard error) 134 (24.6)
After 18 months ART, cells/mm3 (standard error) 161 (35.9)
Switch of ART regimen (n = 11) Intolerance to stavudine (switch to zidovudine), n 4
Intolerance to nevirapine (switch to efavirenz), n 6
Switch to 2nd line (failure conﬁ  rmed by viral load), n 1 
aCases with any missing values were excluded.
IQR, interquartile range
doi:10.1371/journal.pmed.0040204.t001
June 2007  |  Volume 4  |  Issue 6  |  e204PLoS Medicine  |  www.plosmedicine.org 0991
Patient Transfer and Release
Bangkok prisons are overcrowded 
and transfers to less crowded prisons 
elsewhere in the country are common. 
Such transfers create problems for 
ensuring continuity of treatment 
because most prisons outside Bangkok 
have limited health staff and no access 
to HIV treatment. While efforts are 
made to communicate the particular 
health needs of people with HIV/AIDS 
within the prison system, the reality 
is that we do not know what care is 
provided for the ﬁ  ve patients from our 
cohort who have been transferred to 
other prisons.
Continuity of care upon release 
is also challenged by substance use, 
homelessness, joblessness, poverty, 
and difﬁ  culties in accessing the health 
insurance scheme, especially for ex-
prisoners without an ID card (Box 3). 
Before being released from prison, 
patients meet with a social worker 
employed by MSF to develop a plan for 
continuing treatment. In both prisons, 
MSF provides a medication supply 
for three months—the average time 
taken for people with a correct Thai ID 
card to enrol in the government ART 
program. Of 18 prisoners released since 
the start of the treatment programme, 
seven receive treatment through the 
public health system, while six receive 
treatment from MSF because they lack 
a Thai ID card. Despite considerable 
efforts, ﬁ  ve have been lost to follow up.
Ethical Considerations 
Surrounding This Article
Ethical questions inevitably arise 
during any intervention amongst 
incarcerated populations. In this paper 
we have described our experience 
of implementing proven HIV 
prevention strategies and delivering 
standard treatment to a difﬁ  cult-
to-reach population requiring an 
innovative approach. The main 
ethical challenges we have faced, 
together with our partners, have been 
the implementation of practices of 
conﬁ  dentiality and informed consent; 
we have done our best to rise to these 
challenges.
During the peer review process for 
this article, a number of questions 
related to ethics were raised, speciﬁ  cally 
concerns about patient anonymity and 
the need for ethical approval for such a 
publication. The matter was referred to 
the PLoS Medicine Advisory Group on 
Publication Ethics, who were divided 
on the matter [12]. We referred the 
issue to an independent institutional 
review board, whose judgement was 
that there was minimal risk of harming 
individuals or the community by 
publishing this paper. The board also 
felt that as a descriptive paper in which 
no research hypothesis was being tested 
and no analytic statistics were used, 
there was no requirement for formal 
ethics committee review and approval.
Discussion
There are few examples of HIV/AIDS 
treatment programmes in prisons 
in the developing world. Emerging 
outcomes from pilot programmes 
support the effectiveness of treatment 
in prisons [13–15], but poor or non-
availability of antiretrovirals is still 
frequently reported [16–18]. This lack 
of availability has become a growing 
concern for treatment activists: in 
South Africa, civil society groups have 
recently taken the government to 
court to ﬁ  ght for prisoners’ rights to 
treatment [19].
In our experience, satisfactory 
outcomes can be achieved in under-
resourced prison settings. MSF’s initial 
input was to provide treatment for 
opportunistic infections, antiretroviral 
drugs, and technical support. Thailand 
is not a “least-developed” country, 
but the approach taken follows 
WHO guidelines for treatment in 
resource-poor settings, and could 
be implemented by any government 
providing treatment in the general 
population. Ultimately, barriers that 
prevent the provision of treatment in 
prisons when it is available outside are 
not technical or ﬁ  nancial, but political.
The effectiveness of any prison 
programme depends on the attitude 
of staff. We have found the attitude of 
prison health staff to be very positive 
towards the rights of prisoners, but 
this is not yet the case for all staff. 
Treatment provision was an important 
ﬁ  rst step towards building sufﬁ  cient 
trust that then allowed us to bring up 
the more sensitive issue of prevention.
We believe the programme will have 
a sustained impact. The prevention 
component includes strategies to 
change the attitudes and behaviour of 
both prison guards and prisoners, and 
the Department of Corrections has 
asked us to develop training curricula 
to be used in other prisons. In terms 
of treatment, drug supply has been 
handed over to the government and 
training and mentoring has provided 
prison medical staff with the skills to 
manage most problems. Sustainability 
also comes from the fact that part of 
the budget for health care for Thai 
prisoners, including antiretroviral 
medicines, now comes under the 
health insurance scheme. However, 
Thai ethnic minorities and foreigners 
are not eligible for this support and 
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Box 3. Ensuring Continuity of Care after Release from Prison: Case 
Studies
The ﬁ  rst patient is a 33-year-old Thai man who lost his ID card many years ago. He 
was found to be HIV positive whilst in Minburi Remand Prison and began antiretroviral 
therapy in May 2004. He contacted MSF many times for reassurance that he could 
continue treatment after his release.
He was released in October 2005, stayed with friends to whom he did not disclose 
his HIV status, and worked as a welder. MSF supplied his medication and arranged 
lab monitoring. Documentation he needed in order to apply for an ID card included 
his birth certiﬁ  cate, his father’s death certiﬁ  cate, a certiﬁ  cate of release from prison, 
proof of residence—which required the house owner to add his name to a household 
registration document—and two certiﬁ  cates of good character signed by state 
employees. MSF helped him through the necessary bureaucratic procedures and he 
received his ID card in February 2007—16 months after release. This enabled him to 
register with the National Health Insurance scheme and, after a further three months, 
receive treatment through the government program.
The second patient is a 30-year-old man diagnosed with HIV in 2002 in Minburi 
Remand Prison. He did not attend the clinic while in prison but asked MSF to visit him 
upon his release in May 2004. Subsequently he was diagnosed with miliary tuberculosis 
and then commenced ART in May 2005 after MSF helped link him to the government 
ART program. He had previously injected drugs and started again in June 2005. 
However, his adherence to ART remains good.PLoS Medicine  |  www.plosmedicine.org 0992
their access to care is a pressing 
concern.
Most prisoners come from 
marginalised groups such as drug users, 
sex workers, or unregistered migrants. 
These groups are at high risk of HIV 
with limited access to health care in 
general, and this is reﬂ  ected in the 
high number of HIV-positive cases 
diagnosed in the prison. Implementing 
treatment and prevention programmes 
in prisons provides an opportunity to 
work with particular groups who would 
not normally seek, or be given, care. 
An effective response must therefore 
confront barriers to care outside of 
prisons, in order to ensure continuity 
of care for those who are released.
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